
NVIDIA Partners with Eli Lilly, Thermo Fisher to Drive BioNeMo AI Drug Discovery Platform
NVIDIA is expanding its BioNeMo AI platform through partnerships with pharmaceutical leaders Eli Lilly and Thermo Fisher Scientific. The strategy positions NVIDIA as a biotech infrastructure provider while catalyzing a broader ecosystem of competing AI foundation models from startups including Terray Therapeutics, Owkin, and Basecamp Research.
















